BIK-311

N/A

Report date: 2025/08/20 17:35:33
NME

Base Information

Drug NameBIK-311
Drug Alias NameBIK-311
ClassificationSmall molecules
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBIK Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBIK Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A